AJMC - The American Journal of Managed Care’s Post

As the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting concludes, we reflect on the innovative discoveries unveiled this year. In a new article, Henar Hevia, Senior Director and EMEA Therapeutic Area Lead for Oncology, goes one step further, delving into the past, present as well as the future of lung cancer care, since the ground-breaking identification of EGFR mutations in lung cancer, and how this has paved the way for improved patient outcomes. Read it here: https://lnkd.in/eH5tTg5G #ASCO24 #PrecisionMedicine #LungCancer #InFrontOfCancer

In a VuMedi interview, SCRI expert, Dr. Erika Hamilton shares "The Future of Oral SERDs in Breast Cancer". Watch the full interview today.  https://lnkd.in/etFQ6J8C #SABCS23 #BreastCancer #OncologyExpert #ClinicalTrials #advancingscience #transformingcare #cancercare

Our Lung Cancer Screening Registry serves to help increase early lung cancer detection. Ella Kazerooni, MD, MS, FACR, and Ben Wandtke, MD, MS, highlight an opportunity to expand the registry in the latest #VoiceofRadiology blog. (🔗 in comments)

Did you wear pink today? 18 October is #WearItPink day to raise awareness of breast cancer and help fund life-saving breast cancer research and life-changing support. To mark the occasion, why not take a look at our 'Oncology under the microscope' infographic? From the region where breast cancer is most prevalent to the growth of the market up to 2025, there's a lot to discover. Discover here: https://hubs.la/Q02TYDMK0

Are you up to speed on treating HER2-low breast cancer? Strengthen your ability to describe the current strategies and unmet needs of HER2-low breast cancer management as well as to contextualize and interpret new data in the future. https://lnkd.in/gT2YY3H3

Wonderful summary from Dr. Shanu Modi

On World Lung Cancer Day, we join the global community in raising awareness about a disease we know all too well. Advancing and accelerating oncology research is core to who we are. See Precision experts in action in an international Phase 1 trial for NSCLC: https://hubs.ly/Q02JJG1h0 #oncology #clinicaltrials #clinicalresearch

Big ups to Russell C. Langan, MD, FACS, FSSO and RWJBarnabas Health for winning the 14th annual ACCC Innovator Awards which recognize visionary and compelling ideas in oncology from the ACCC! “In the 2 years following program implementation, 82 pancreatic cancers were detected from incidental findings with 65% of patients being diagnosed in earlier stages (stages I, II, and III), as well as instances of ampullary cancer, gallbladder cancer, and gastric cancer.” #defydisease https://lnkd.in/geeHnxAQ

"After 14 months on a regimen of intravenous chemotherapy for metastatic breast cancer, Dr. Kelly Shanahan, switched to an oral treatment with an aromatase inhibitor." Have you read CURE Magazine's latest issue? Learn more about new tools to help manage ESR1 mutations in metastatic breast cancer. Subscribe here: https://ow.ly/rGz850Qv17j

October is National Breast Cancer Month. A time annually devoted to educating and early detection of breast cancer. Early detection—finding cancer before it spreads—is critical. Here is a free guide to learn ways to identify breast cancer by being proactive: https://lnkd.in/eRq9PX2